Holen Sie sich die Stockscreener-App
1.01
3.69%
0.0359
Schlusskurs vom Vortag:
$0.9741
Offen:
$1.01
24-Stunden-Volumen:
181.52K
Relative Volume:
0.97
Marktkapitalisierung:
$13.62M
Einnahmen:
$17.44M
Nettoeinkommen (Verlust:
$-21.23M
KGV:
-0.4517
EPS:
-2.2361
Netto-Cashflow:
$-17.60M
1W Leistung:
-17.21%
1M Leistung:
-17.21%
6M Leistung:
-64.56%
1J Leistung:
-51.90%
1-Tages-Spanne:
$0.99
$1.0398
1-Wochen-Bereich:
$0.9601
$1.54
52-Wochen-Spanne:
$0.9601
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Firmenname
Vivos Therapeutics Inc
Sektor
Branche
Telefon
(866)908-4867
Adresse
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.01 | 13.14M | 17.44M | -21.23M | -17.60M | -2.2361 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
Vivos Therapeutics stock price target lowered to $2.50 by H.C. Wainwright - Investing.com Canada
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM ESTShow #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Viv - ACCESS Newswire
H.C. Wainwright Maintains Vivos Therapeutics(VVOS.US) With Buy Rating, Cuts Target Price to $2.5 - 富途牛牛
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2025 Earnings Call Transcript - Insider Monkey
Vivos targets cash flow positive operations by end of 2026 as it scales SO teams with $500,000+ monthly collections potential - MSN
Vivos Therapeutics Balances Growth Hopes With Cash Strain - TipRanks
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
Vivos Therapeutics Reports 16% Revenue Growth in 2025, Advances Sleep Center Integration and Eyes Cash Flow Positive Operations - Minichart
Vivos Therapeutics Pivots to Medical-Provider Focused Model with Sleep Center of Nevada Acquisition to Expand Sleep Apnea Solutions 91 - Minichart
Earnings call transcript: vivos beats Q4 2025 earnings expectations - Investing.com UK
VVOS: 2025 revenue rose 16% as SCN integration fueled growth, with further expansion planned for 2026 - TradingView
Earnings Call Summary | Vivos Therapeutics(VVOS.US) Q4 2025 Earnings Conference - 富途牛牛
VVOS: 2025 revenue up 16% from SCN integration, with strong growth outlook as new model scales - TradingView
Earnings call transcript: vivos beats Q4 2025 earnings expectations By Investing.com - Investing.com India
Vivos Therapeutics Q4 2025 Earnings Call Transcript - MarketBeat
Form 8-KCurrent report - ADVFN
Vivos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vivos Therapeutics (NASDAQ: VVOS) details SCN deal and new sleep-center strategy - Stock Titan
Vivos Therapeutics Reports Full Year 2025 Financial Results - The Manila Times
Vivos grows on sleep apnea services, but operating loss hits $19.9M - Stock Titan
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results - National Today
Vivos Therapeutics, Inc. to Release Full Year 2025 Financial Results and Conduct Conference Call on April 15, 2026 - Quiver Quantitative
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call - marketscreener.com
Vivos investors get 2025 results and strategy update at 5 p.m. ET - Stock Titan
Vivos Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Broadcom, Vivos Therapeutics and 3 stocks to watch heading into Monday - MSN
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ - ACCESS Newswire
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Hilton Head Island Packet
Vivos Therapeutics (VVOS) 10% holder reports large stock and warrant stakes - Stock Titan
VVOS Stock Chart | VIVOS THERAPEUTICS INC (NASDAQ:VVOS) - ChartMill
Resistance Check: Can Vivos Therapeutics Inc maintain its current growth rate2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
VVOS|Vivos Therapeutics Inc|Price:1.190|Chg%:-0.05 - TradingKey
VVOS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vivos Therapeutics closes $2.25M private placement with Seneca By Investing.com - Investing.com Canada
Vivos Therapeutics closes $2.25M private placement with Seneca - Investing.com
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners - marketscreener.com
Sleep-disorder company Vivos gets $2.25M from repeat investor - Stock Titan
Portfolio Update: How does Vivos Therapeutics Inc score in quality rankingsTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into MondayBroadcom (NASDAQ:AVGO) - Benzinga
Vivos Therapeutics Enters Securities Purchase Agreement with V-CO Investors 3 LLC and Issues New Warrants – Form 8-K Filing Details - Minichart
VVOS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VVOS Technical Analysis & Stock Price Forecast - Intellectia AI
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - Stock Titan
Vivos Therapeutics Completes Private Placement to Bolster Liquidity - The Globe and Mail
Vivos Therapeutics Secures $0.85M PIPE, Converts $1.4M Bridge Note With Seneca Affiliate - TradingView — Track All Markets
Vivos Therapeutics (NASDAQ: VVOS) gets $850,000 PIPE cash plus $1,400,000 bridge note conversion - Stock Titan
Why did Vivos Therapeutics (VVOS) stock jump over 21% after hours - MSN
Vivos Therapeutics investor V-Co investors 3 LLC buys shares worth $1.8m By Investing.com - Investing.com
Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours - Benzinga
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):